Colon cancer stem cells resist antiangiogenesis therapy-induced apoptosis

Cancer Letters

Volumn 328, Issue 2, 2013, Pages 226-234

  Lin, Shih Pei ^a,b   Lee, Yi Ting ^a,b   Yang, Shung Haur ^a   Miller, Stephanie A ^c   Chiou, Shih Hwa ^a,b   Hung, Mien Chie ^c,d   Hung, Shih Chieh ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c UNIVERSITY OF TEXAS   (United States)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Avastin; Cancer stem cells; Colon cancer; Hypoxia; Serum free

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BEVACIZUMAB; C6 CERAMIDE; CD133 ANTIGEN; CERAMIDE DERIVATIVE; HEAT SHOCK PROTEIN 27; MITOGEN ACTIVATED PROTEIN KINASE ACTIVATED PROTEIN KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; OKADAIC ACID; PACLITAXEL; PHOSPHATE BUFFERED SALINE; PROTEIN SERINE THREONINE KINASE; QUERCETIN; SUNITINIB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC THERAPY; APOPTOSIS; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STEM CELL; CELL POPULATION; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR XENOGRAFT;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; GLYCOPROTEINS; HSP27 HEAT-SHOCK PROTEINS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; PROTEIN PHOSPHATASE 2; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84870329341     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.08.036     Document Type: Article

References (27)

1. Jordan C.T. Cancer stem cell biology: from leukemia to solid tumors. Curr. Opin. Cell Biol. 2004, 16:708-712.
2. Jacobs J.J., Kieboom K., Marino S., DePinho R.A., van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999, 397:164-168.
3. Park I.K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., Morrison S.J., Clarke M.F. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003, 423:302-305.
4. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
5. Todaro M., Alea M.P., Di Stefano A.B., Cammareri P., Vermeulen L., Iovino F., Tripodo C., Russo A., Gulotta G., Medema J.P., Stassi G. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007, 1:389-402.
6. Iqbal S., Lenz H.J. Angiogenesis inhibitors in the treatment of colorectal cancer. Semin. Oncol. 2004, 31:10-16.
7. Ebos J.M., Lee C.R., Cruz-Munoz W., Bjarnason G.A., Christensen J.G., Kerbel R.S. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009, 15:232-239.
8. Paez-Ribes M., Allen E., Hudock J., Takeda T., Okuyama H., Vinals F., Inoue M., Bergers G., Hanahan D., Casanovas O. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009, 15:220-231.
9. Conley S.J., Gheordunescu E., Kakarala P., Newman B., Korkaya H., Heath A.N., Clouthier S.G., Wicha M.S. Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc. Natl. Acad. Sci. USA 2012, 109:2784-2789.
10. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
11. O'Brien C.A., Pollett A., Gallinger S., Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
12. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., Pastorino S., Purow B.W., Christopher N., Zhang W., Park J.K., Fine H.A. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006, 9:391-403.
13. Dallas N.A., Xia L., Fan F., Gray M.J., Gaur P., van Buren G., Samuel S., Kim M.P., Lim S.J., Ellis L.M. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res. 2009, 69:1951-1957.
14. Tozer G.M. Measuring tumour vascular response to antivascular and antiangiogenic drugs. Br. J. Radiol. 2003, 76(Spec No.1):S23-S35.
15. W.H. Huang, M.C. Chang, K.S. Tsai, M.C. Hung, H.L. Chen, S.C. Hung, Mesenchymal stem cells promote growth and angiogenesis of tumors in mice, Oncogene (2012).
16. - metastatic colon cancer cells initiate tumors. J. Clin. Invest. 2008, 118:2111-2120.
17. Mumby M. PP2A: unveiling a reluctant tumor suppressor. Cell 2007, 130:21-24.
18. Cairns J., Qin S., Philp R., Tan Y.H., Guy G.R. Dephosphorylation of the small heat shock protein Hsp27 in vivo by protein phosphatase 2A. J. Biol. Chem. 1994, 269:9176-9183.
19. Rouse J., Cohen P., Trigon S., Morange M., Alonso-Llamazares A., Zamanillo D., Hunt T., Nebreda A.R. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 1994, 78:1027-1037.
20. Dobrowsky R.T., Hannun Y.A. Ceramide stimulates a cytosolic protein phosphatase. J. Biol. Chem. 1992, 267:5048-5051.
21. Loktionova S.A., Kabakov A.E. Protein phosphatase inhibitors and heat preconditioning prevent Hsp27 dephosphorylation, F-actin disruption and deterioration of morphology in ATP-depleted endothelial cells. FEBS Lett. 1998, 433:294-300.
22. Bruey J.M., Ducasse C., Bonniaud P., Ravagnan L., Susin S.A., Diaz-Latoud C., Gurbuxani S., Arrigo A.P., Kroemer G., Solary E., Garrido C. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat. Cell Biol. 2000, 2:645-652.
23. Paul C., Manero F., Gonin S., Kretz-Remy C., Virot S., Arrigo A.P. Hsp27 as a negative regulator of cytochrome C release. Mol. Cell. Biol. 2002, 22:816-834.
24. Pandey P., Farber R., Nakazawa A., Kumar S., Bharti A., Nalin C., Weichselbaum R., Kufe D., Kharbanda S. Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3. Oncogene 2000, 19:1975-1981.
25. Okamoto T. Safety of quercetin for clinical application (Review). Int. J. Mol. Med. 2005, 16:275-278.
26. Junttila M.R., Puustinen P., Niemela M., Ahola R., Arnold H., Bottzauw T., Ala-aho R., Nielsen C., Ivaska J., Taya Y., Lu S.L., Lin S., Chan E.K., Wang X.J., Grenman R., Kast J., Kallunki T., Sears R., Kahari V.M., Westermarck J. CIP2A inhibits PP2A in human malignancies. Cell 2007, 130:51-62.
27. Sablina A.A., Chen W., Arroyo J.D., Corral L., Hector M., Bulmer S.E., DeCaprio J.A., Hahn W.C. The tumor suppressor PP2A Abeta regulates the RalA GTPase. Cell 2007, 129:969-982.